PyInvesting

Market research

RH7.F Ryman Healthcare Limited

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
965M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
0.34

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Ryman Healthcare Limited is currently in a long term downtrend where the price is trading 8.8% below its 200 day moving average.

From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.9.

Finally, its free cash flow fell by 112.8% to $-16M since the same quarter in the previous year.

Based on the above factors, Ryman Healthcare Limited gets an overall score of 1/5.